FDA全球物质注册数据库(FDA Global Substance Registration System)
物质名称VANUCIZUMAB
异名/同义词BISPECIFIC HUMAN ANTI-ANG-2/ANTI-VEGF-A ANTIBODY
BISPECIFIC HUMAN ANTI-ANG-2/ANTI-VEGF-A MONOCLONAL ANTIBODY
C0U97738AE
IMMUNOGLOBULIN RECOMBINED G1-KAPPA/LAMBDA, ANTI-(HOMO SAPIENS ANGPT2 (ANGIOPOIETIN 2, ANG2))/ANTI-HOMO SAPIENS VEGFA (VASCULAR ENDOTHELIAL GROWTH FACTOR A, VEGF-A, VEGF)), HUMANIZED MONOCLONAL ANTIBODY
RG7221
RG-7221
RO5520985
RO-5520985
VANUCIZUMAB
VANUCIZUMAB [INN]
VANUCIZUMAB [USAN]
VANUCIZUMAB [WHO-DD]
CAS登记号1448221-05-3
物质唯一标识(Unique Ingredient Identifier)B800Z06O8K
分子式
国际化合物标识(International Chemical Identifier,InChI)
SMILES
分子结构式
欧洲化学品管理局注册号(ECHA)
成分类型INGREDIENT SUBSTANCE / protein
关联数据
  • 药品国际非专利名称数据库
  • 世界卫生组织药物词典
扩展资源
©2006-2024 Drugfuture->FDA Global Substance Registration System